VANCOUVER, Wash. and NEW YORK - Absci Corporation (NASDAQ:ABSI) announced today the formation of an advisory board for its ABS-201 program, a therapeutic antibody treatment in clinical development for ...

TORONTO, March 5, 2026 /CNW/ - A Women's Work (AWW Org) today announced the launch of the MODWORKS Program: 2026 Training Module, a one-week intensive modular construction training program designed ...

VANCOUVER, Wash. - Absci Corporation (Nasdaq:ABSI) appointed Ransi Somaratne as Chief Medical Officer, the company said in a statement today. Somaratne joins from Vertex Pharmaceuticals, where he ...

Olympic Champion Nathan Chen recaps the Men's Short Program from Milan, Italy and explains why the U.S. figure skating star could only be 'competing with himself' in the free skate We just finished ...

SOUTH VIENNA — The state of Ohio has launched the Ohio-See program to provide children in need with mobile eye exams and prescription glasses directly at their schools. Students at Northeastern ...

In interviews to Defence 24, Deputy General Commander Maj. Gen. Ireneusz Nowak pointed to the need for a new AEW&C platform, given the limited remaining lifespan of the Saab 340s. The Polish Air Force ...

The Pentagon is looking to launch a new Enterprise Command and Control Program Office in a move that would consolidate and refresh its long-standing efforts to provide common operating panes and ...

Good morning, everyone. Thank you for joining our deep dive today into ABS-201. At Absci, our mission is to use generative AI to create better biologics for patients who don't have good enough options ...

ABS issued approval in principle (AIP) to Hanwha Ocean Co. Ltd. for remote control functions for FPSO units. ABS completed design reviews based on the ABS Requirements for Autonomous and ...

Microsoft’s agent factory vision now comes with some data and security controls. Microsoft’s agent factory vision now comes with some data and security controls. is a senior editor and author of ...

VANCOUVER, Wash. and NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the ...